|
18F-FCH Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2/3: 1
Top Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Indications
- Hyperparathyroid-jaw Tumor Syndrome1
- Heritable Hyperparathyroidism1
- Multiple Endocrine Neoplasias1
- Primary Hyperparathyroidism1
- Parathyroid Cancer1
Bethesda, Maryland1 trial
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
National Institutes of Health Clinical Center
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.